GSWM
TMDX icon

Golden State Wealth Management’s Transmedics TMDX Stock Holding History

Golden State Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465 Sell
7
-75
-91% -$6.35K ﹤0.01% 1547
2026
Q1 		$8.15K Hold
82
– – ﹤0.01% 1128
2025
Q4 		$9.98K Buy
82
+62
+310% +$7.78K ﹤0.01% 1105
2025
Q3 		$2.24K Buy
+20
New +$2.34K ﹤0.01% 1374

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Golden State Wealth Management's TMDX Position: Q2 2026 in Review

Golden State Wealth Management reduced its Transmedics (TMDX) stake by 91% in Q2 2026, selling an estimated $6.35K and leaving 7 shares worth $465. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Golden State Wealth Management first reported a position in TMDX in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.98K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Golden State Wealth Management held 7 shares of Transmedics worth $465 as of Q2 2026.
  • Golden State Wealth Management sold 75 Transmedics shares in Q2 2026, an estimated $6.35K.
  • Transmedics made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1547 holding.
  • Golden State Wealth Management first reported a position in Transmedics in Q3 2025 and has held it in 4 quarters since.
  • Golden State Wealth Management's Transmedics position peaked at $9.98K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.